| ABO | AS | NT | |||
| O | 41.5-47.1% (44.3%) | 43.0-49.4% (46.2%) | |||
| A | 33.6-39.0% (36.3%) | 31.9-38.1% (35.0%) | |||
| B | 9.6-13.1% (11.3%) | 9.3-13.4% (11.3%) | |||
| AB | 6.5-9.5% (8.0%) | 5.8-9.2% (7.5%) | 
| ABO | AS | NT | |||
| O | 42.1-47.7% (44.9%) | 42.7-49.5% (46.1%) | |||
| A | 33.5-39.0% (36.2%) | 32.2-38.7% (35.4%) | |||
| B | 9.3-12.9% (11.1%) | 9.5-13.9% (11.7%) | |||
| AB | 6.2-9.3% (7.8%) | 5.1-8.5% (6.8%) | 
| ABO | AS | NT | |||
| O | 12.1-40.5% (26.3%) | 36.9-57.6% (47.3%) | |||
| A | 23.7-55.2% (39.5%) | 21.2-40.3% (30.8%) | |||
| B | 5.9-30.9% (18.4%) | 2.2-13.2% (7.7%) | |||
| AB | 4.0-27.5% (15.8%) | 7.1-21.5% (14.3%) |